Company: Vivet Therapeutics
Job title: Co-Founder & Chief Executive Officer
Jean-Philippe has 26 years of experience in the pharma & biotech industries. He is a highly skilled senior executive with a broad range of experience leading global development and a successful track record of innovation and development in the area of Orphan Drugs. Jean-Philippe earned his PhD in Toxicology and Pharm.D from Paris XI University and holds a Master’s in Strategic Marketing from ESCP Paris as well as a General Management Program from center of executive development at INSEAD.
Clinical Safety Monitoring for AAV Gene Therapies 101 8:30 am
A major objective of early-phase clinical trials is the safety evaluation of a drug candidate. With gene therapies, a complex mixture of difficult-to-predict immediate hypersensitivity and delayed immune reactions can occurs from anywhere between minutes and months of administration. As such, it is vitally important to outline the immune monitoring strategies as part of your…Read more
day: Pre-Conference Day